2019 launch Dream Lady starring Ayushmann Khurrana and Nushrratt Bharuccha was an excellent hit on the field workplace. Now, the makers are planning a sequel to it and Ayushmann will return to the franchise. Nevertheless, it isn’t but recognized which actress can be seen as the feminine lead within the film. Earlier, there have been experiences that Naagin 6 Tejasswi Prakash can be making her Bollywood debut with Dream Lady 2. Later, it was reported that not Tejasswi however Sara Ali Khan may romance Ayushmann. Nevertheless, now, right here’s yet one more report in regards to the movie’s main girl.
In line with a report in Pinkvilla, the makers have roped in Ananya Panday for Dream Lady 2. A supply informed the portal that the makers had been in talks with Ananya for the movie and at last she has been finalised.
Properly, if this report seems to be true, will probably be fascinating to observe Ananya and Ayushmann Khurrana’s contemporary pairing on the massive display screen. In the meantime, Ananya is at the moment busy with the promotions of Liger which additionally stars Vijay Deverakonda within the lead position.
Whereas Liger will mark Vijay’s Hindi debut, will probably be Ananya’s Telugu debut. The movie is shot in Hindi and Telugu, and will probably be dubbed and launched in different languages like Tamil, Malayalam, and Kannada. It’s slated to hit the massive screens on twenty fifth August 2022. Aside from Liger, Ananya has Kho Gaye hum Kahan lined up.
Speaking about Ayushmann, the actor has Physician G and An Motion Hero lined up. He was final seen Anek which did not make a mark on the field workplace. Physician G, which additionally stars Rakul Preet Singh and Shefali Shah, was slated to launch in June this yr, nevertheless it has been postponed.
Keep tuned to BollywoodLife for the most recent scoops and updates from Bollywood, Hollywood, South, TV and Net-Sequence.
Click on to affix us on Fb, Twitter, Youtube and Instagram.
Additionally observe us on Fb Messenger for contemporary updates.
// jQuery(window).scroll(function(){ // if (isInView(jQuery('#live-blog-update'))){ // getMoreBlogEntries(); // } // });
$(document).ready(function(){ $('#commentbtn').on("click",function(){ (function(d, s, id) { var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src="https://connect.facebook.net/en_US/sdk.js#xfbml=1&version=v3.0&appId=179720252061082&autoLogAppEvents=1"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));
$(".cmntbox").toggle(); }); });